Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-24
1996-12-10
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514307, 514573, A61K 31445, A61K 3147, A61K 31557
Patent
active
055831443
ABSTRACT:
The present invention relates to methods of relieving erectile impotence in a human male. The method comprises administering to the male an erectile impotence relieving amount of piperoxan and the compositions include an erectile impotence relieving amount of piperoxan or the pharmaceutically acceptable acid addition salts thereof optionally in combination with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 2056046 (1936-09-01), Fourneau
patent: 4127118 (1978-11-01), Latorre
patent: 5145852 (1992-09-01), Virag
patent: 5236904 (1993-08-01), Gerstenberg et al.
patent: 5242391 (1993-09-01), Place et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5336678 (1994-08-01), Cavallini
patent: 5399581 (1995-03-01), Laragh
patent: 5451609 (1995-09-01), Bellamy et al.
Morales, et al., Is Yohimbine Effective in the Treatment of Organic Impotence? Results of a Controlled Trial, the Journal of Urology 137: 1168-1172 (1987).
Shabsigh et al., Evaluation of Erectile Impotence, Urology 32: 83-90 (1988).
Juenemann, et al., Hemodynamics of Papaverine and Phentolamine-induced Penile Erection, The Journal of Urology 136: 158-161 (1986).
Levine et al., Side-effects of Self-administration of Intracavernous Papaverine and Phentolamine for the Treatment of Impotence, The Journal of Urology 141: 54-57 (1989).
Stackl et al., Intracavernous Injection of Prostaglandin E1 in Impotent Men, the Journal of Urology 140: 66-68 (1988).
Schramek et al., Dose-dependent Effect and Side Effect of Prostaglandin E1 in Erectile Dysfunction, The British Journal of Clinical Pharmacology 38: 567-571 (1989).
Lee et al., Prostaglandin E1 versus Phentolamine/Papaverine for the Treatment of Erectile Impotence: A Double-blind Comparison, The Journal of Urology 141: 549-550 (1989).
Stief et al., Preliminary Results with the Nitric Oxide Donor Linsidomine Chlorhydrate in the Treatment of Human Erectile Dysfunction, The Journal of Urology 148: 1437-1440 (1992).
De Tejada et al., Pathophysiology of Prolonged Penile Erection Associated with Trazodone Use, the Journal of Urology 145: 60-64 (1991).
Halsted et al., Papaverine-induced Priapism: 2 Case Reports, The Journal of Urology 136: 109 (1986).
Brindley, G. S., Pilot Experiments on the Actions of Drugs Injected Into the Human Corpus Cavernosum Penis, British Journal of Pharmacology 87: 495-500 (1987).
Azadzoi et al., Effects of Intracavernosal Trazodone Hydrochloride: Animal and Human Studies, The Journal of Urology 144:1277-1282 (1990).
Perrone et al., Napamezole, an Alpha-2 Adrenergic Receptor Antagonist and Monoamine Uptake Inhibitor In Vitro, the Journal of Pharmacology and Experimental Therapeutics 254: 471-475 (1990).
Hsu et al, Chemical Abstracts, vol. 102, No. 5, 1985, abstract #41265h, p. 177.
Cintins Marianne M.
Ferraro Gregory
Jarvis William R. A.
LandOfFree
Methods for treating erectile impotence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating erectile impotence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating erectile impotence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424456